Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway

Abstract

THE hepatitis B virus (HBV) transactivator protein HBx is enigmatic in that it stimulates a striking variety of promoters which do not share a common cis-regulatory element1–5. As it does not bind to DNA6,7, it has been speculated that HBx acts indirectly through cellular pathways4,6–8. Under certain conditions HBx can have an oncogenic potential, which may be relevant for HBV-associated liver carcinogenesis9–11, but until now the mechanism for transactivation and cell transformation by HBx was unclear. We report here that HBx uses a complex signal transduction pathway for transactivation. An increase in the endogenous protein kinase C (PKC) activator sn-l,2-diacylglycerol and the subsequent activation of PKC give rise to activation of the transcription factor AP-1 (Jun–Fos). As a result, HBx transactivates through binding sites for AP-1 and other PKC-dependent transcription factors (AP-2, NF-κB), thereby explaining the as-yet incomprehensible variety of HBx-inducible genes. As the PKC signal cascade also mediates cell transformation by tumour-promoting agents, the mechanism presented here might account for the oncogenic potential of HBx.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Zahm, P., Hofschneider, P. H. & Koshy, R. Oncogene 3, 169–177 (1988).

    CAS  PubMed  Google Scholar 

  2. Twu, J. & Schloemer, R. H. J. Virol. 61, 3448–3453 (1987).

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Spandau, D. F. & Lee, C. J. Virol. 62, 427–434 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Seto, E., Mitchell, P. J. & Yen, T. B. Nature 344, 72–74 (1990).

    Article  ADS  CAS  PubMed  Google Scholar 

  5. Rossner, M. T. J. med. Virol. 36, 101–117 (1992).

    Article  CAS  PubMed  Google Scholar 

  6. Faktor, O. & Shaul, Y. Oncogene 5, 867–872 (1990).

    CAS  PubMed  Google Scholar 

  7. Siddiqui, A., Jameel, S. & Mapoles, J. Proc. natn. Acad. Scl. U.S.A. 84, 2513–2517 (1987).

    Article  ADS  CAS  Google Scholar 

  8. Wu, J. Y., Zhuo, Z.-Y., Judd, A., Cartwright, C. A. & Robinson, W. S. Cell 63, 687–695 (1990).

    Article  CAS  PubMed  Google Scholar 

  9. Höhne, M. et al. EMBO J. 9, 1137–1145 (1990).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kim, C.-M., Koike, K., Saito, I., Miyamura, T. & Jay, G. Nature 351, 317–320 (1991).

    Article  ADS  CAS  PubMed  Google Scholar 

  11. Seifer, M., Höhne, M., Schaefer, S. & Gerlich, W. H. J. Hepatology 13, S61–S65 (1991).

    Article  CAS  Google Scholar 

  12. Angel, P. & Karin, M. Biochim. biophys. Acta 1072, 129–157 (1991).

    CAS  PubMed  Google Scholar 

  13. Müller, U., Roberts, M. P., Engel, D. A., Doerfler, W. & Shenk, T. Genes Dev. 3, 1991–2002 (1989).

    Article  PubMed  Google Scholar 

  14. Nishizuka, Y. Nature 334, 661–665 (1988).

    Article  ADS  CAS  PubMed  Google Scholar 

  15. Büscher, M., Rahmsdorf, H. J., Litfin, M., Karin, M. & Herrlich, P. Oncogene 3, 301–311 (1988).

    PubMed  Google Scholar 

  16. Lucito, R. & Schneider, R. J. J. Virol. 66, 983–991 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Exton, J. H. J. biol. Chem. 265, 1–4 (1990).

    CAS  PubMed  Google Scholar 

  18. Lacal, J. C., Joscat, J. & Aaronson, S. A. Nature 220, 269–272 (1987).

    Article  ADS  Google Scholar 

  19. Song, J., Pfeffer, L. M. & Foster, D. A. Molec. cell. Biol. 11, 4903–4908 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Wasylyk, C., Imler, J. L., Perez-Mutul, J. & Wasylyk, B. Cell 48, 525–534 (1987).

    Article  CAS  PubMed  Google Scholar 

  21. Maguire, H. F., Hoeffler, J. P. & Siddiqui, A. Science 252, 842–844 (1991).

    Article  ADS  CAS  PubMed  Google Scholar 

  22. Blum, H. E. et al. J. Virol. 66, 1223–1227 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Yaginuma, K., Shirakata, Y., Kobayashi, M. & Koike, K. Proc. natn. Acad. Sci. U.S.A. 84, 2678–2682 (1987).

    Article  ADS  CAS  Google Scholar 

  24. Housey, G. M. et al. Cell 52, 343–354 (1988).

    Article  CAS  PubMed  Google Scholar 

  25. Baniahmad, A., Steiner, C., Köhne, A. C. & Renkawitz, R. Cell 61, 505–514 (1990).

    Article  CAS  PubMed  Google Scholar 

  26. Wollersheim, M. & Hofschneider, P. H. in Viral Hepatitis and Liver Disease (ed. Zuckermann, A. J.) 334–340 (Liss, New York, 1988).

    Google Scholar 

  27. Graham, F. L. & van der Eb, A. J. Virology 52, 456–467 (1973).

    Article  CAS  PubMed  Google Scholar 

  28. De Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R. & Subramani, S. Molec. cell. Biol. 7, 725–737 (1987).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Gorman, C. M., Moffat, L. F. & Howard, B. H. Molec. cell. biol. 2, 1044–1051 (1982).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Angel, P. Hattori, K., Smeal, T. & Karin, M. Cell 55, 875–885 (1988).

    Article  CAS  PubMed  Google Scholar 

  31. Dignam, J. P., LeBovitz, R. M. & Roeder, R. G. Nucleic Acids Res. 11, 1475–1489 (1983).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hidaka, H., Inagaki, M., Kawamoto, S. & Sasaki, Y. Biochemistry 23, 5036–5041 (1984).

    Article  CAS  PubMed  Google Scholar 

  33. Loomis, C. R. & Bell, R. M. J. biol. Chem. 263, 1682–1692 (1988).

    CAS  PubMed  Google Scholar 

  34. Hannun, Y. A., Loomis, C. R., Merrill, A. H. & Bell., R. M. J. biol. Chem. 261, 12604–12609 (1986).

    CAS  PubMed  Google Scholar 

  35. Toullec, D. et al. J. biol. Chem. 266, 15771–15781 (1991).

    CAS  PubMed  Google Scholar 

  36. Tamaoki, T. et al. Biochem. biophys. Res. Commun. 135, 397–402 (1986).

    Article  CAS  PubMed  Google Scholar 

  37. Asano, T. & Hidaka, H. J. Pharmak. exp. Ther. 231, 141–145 (1984).

    CAS  Google Scholar 

  38. Konig, H. et al. EMBO J. 8, 2559–2566 (1989).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Fabbro, D., Jungmann, R. A. & Eppenberger, U. Arch. Biochem. Biophys. 239, 102–111 (1985).

    Article  CAS  PubMed  Google Scholar 

  40. Van Veldhoven, P. P. & Mannaerts, G. P. Analyt. Biochem. 161, 45–48 (1987).

    Article  CAS  PubMed  Google Scholar 

  41. Preiss, J. et al. J. biol. Chem. 261, 8597–8600 (1986).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kekulé, A., Lauer, U., Weiss, L. et al. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361, 742–745 (1993). https://doi.org/10.1038/361742a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/361742a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing